Security and Privacy
We employ reasonable technical, administrative and physical safeguards to protect the confidentiality and security of your personal information. This includes use of SSL certificates on pages where personal information is entered.
Sharing of Information
We will never sell or rent your personal information to third parties for their use without your consent. We may share your contact and other information with our partners for limited purposes, with certain third parties (who may only use the information for the purpose for which it was provided), with courts, law enforcement and other relevant third parties, or with our acquirer if we are ever acquired.
You always have the opportunity to opt-out or change preferences in our non-transactional email messages to you by following a link in the footer of all non-transactional email messages sent by us or by emailing us at firstname.lastname@example.org
Clinical Trials on Stem-Kine
1. Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
Journal of Translational Medicine 2009, 7:106. Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KWH, Swindlehurst CA, Minev B, Patel A, Murphy MP, Smith L, Alexandrescu DT, Ichim TE, Riordan NH.
ABSTRACT: Endothelial dysfunction is associated with major causes of morbidity and mortality, as well as numerous age-related conditions. The possibility of preserving or even rejuvenating endothelial function offers a potent means of preventing/treating some of the most fearful aspects of aging such as loss of mental, cardiovascular, and sexual function. Endothelial precursor cells (EPC) provide a continual source of replenishment for damaged or senescent blood vessels. In this review we discuss the biological relevance of circulating EPC in a variety of pathologies in order to build the case that these cells act as an endogenous mechanism of regeneration. Factors controlling EPC mobilization, migration, and function, as well as therapeutic interventions based on mobilization of EPC will be reviewed. We conclude by discussing several clinically-relevant approaches to EPC mobilization and provide preliminary data on a food supplement, Stem-Kine, which enhanced EPC mobilization in human subjects…
Link to Full Text
2. Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects
Journal of Translational Medicine 2010, Apr 8;8:34. Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Ramos F, Ichim TE, Riordan NH.
ABSTRACT: The medical significance of circulating endothelial or hematopoietic progenitors is becoming increasing recognized. While therapeutic augmentation of circulating progenitor cells using G-CSF has resulted in promising preclinical and early clinical data for several degenerative conditions, this approach is limited by cost and inability to perform chronic administration. Stem-Kine is a food supplement that was previously reported to augment circulating EPC in a pilot study. Here we report a trial in 18 healthy volunteers administered Stem-Kine twice daily for a 2 week period. Significant increases in circulating CD133 and CD34 cells were observed at days 1, 2, 7, and 14 subsequent to initiation of administration, which correlated with increased hematopoietic progenitors as detected by the HALO assay…
Link to Full Text